ReP USP - Resultado da busca

Artigo de periodico
Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy (2015)
Ruff, Paul; Ferry, David R.; Lakomỳ, Radek; McWalter, Gael; Van Hazel, Guy A.; Hoff, Paulo M.; Cunningham, David; Arnold, Dirk; Schmoll, Hans J.; Moiseyenko, Vladimir M.; McKendrick, Joseph J.; ten Tije, Albert J.; Vishwanath, Raghu L.; Bhargava, Pankaj; Chevalier, Soazig; Macarulla, Teresa; Cutsem, Eric Van
Source: European Journal of Cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS (TERAPIA), FATORES DE CRESCIMENTO, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUFF, Paul et al. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, v. 51, n. 1, p. 18-26, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2014.10.019. Acesso em: 01 maio 2026.
APA
Ruff, P., Ferry, D. R., Lakomỳ, R., McWalter, G., Van Hazel, G. A., Hoff, P. M., et al. (2015). Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy. European Journal of Cancer, 51( 1), 18-26. doi:10.1016/j.ejca.2014.10.019
NLM
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019
Vancouver
Ruff P, Ferry DR, Lakomỳ R, McWalter G, Van Hazel GA, Hoff PM, Cunningham D, Arnold D, Schmoll HJ, Moiseyenko VM, McKendrick JJ, ten Tije AJ, Vishwanath RL, Bhargava P, Chevalier S, Macarulla T, Cutsem EV. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [Internet]. European Journal of Cancer. 2015 ; 51( 1): 18-26.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.ejca.2014.10.019
Trabalho de evento-resumo periodico
Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. (2015)
Coart, Elisabeth; Saad, Everardo D.; Shi, Qian; Sommeijer, Dirkje Willemien; Zalcberg, John Raymond; Maughan, Tim; Goldberg, Richard M.; Schmoll, Hans-Joachim; Punt, Cornelis J. A.; Cutsem, Eric Van; Douillard, Jean-Yves; Hoff, Paulo Marcelo; Tebbutt, Niall C.; Fuchs, Charles S.; Falcone, Alfredo; Tournigand, Christophe; De Gramont, Aimery; Sargent, Daniel J.; Burzykowski, Tomasz; Buyse, Marc E.
Source: Journal of Clinical Oncology. Conference titles: Gastrointestinal Cancers Symposium. Unidade: FM
Subjects: TAXA DE SOBREVIVÊNCIA, NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COART, Elisabeth et al. Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1200/jco.2015.33.3_suppl.666. Acesso em: 01 maio 2026. , 2015
APA
Coart, E., Saad, E. D., Shi, Q., Sommeijer, D. W., Zalcberg, J. R., Maughan, T., et al. (2015). Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. Journal of Clinical Oncology. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1200/jco.2015.33.3_suppl.666
NLM
Coart E, Saad ED, Shi Q, Sommeijer DW, Zalcberg JR, Maughan T, Goldberg RM, Schmoll H-J, Punt CJA, Cutsem EV, Douillard J-Y, Hoff PM, Tebbutt NC, Fuchs CS, Falcone A, Tournigand C, De Gramont A, Sargent DJ, Burzykowski T, Buyse ME. Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2026 maio 01 ] Available from: https://doi.org/10.1200/jco.2015.33.3_suppl.666
Vancouver
Coart E, Saad ED, Shi Q, Sommeijer DW, Zalcberg JR, Maughan T, Goldberg RM, Schmoll H-J, Punt CJA, Cutsem EV, Douillard J-Y, Hoff PM, Tebbutt NC, Fuchs CS, Falcone A, Tournigand C, De Gramont A, Sargent DJ, Burzykowski T, Buyse ME. Trial-level association between response-based endpoints (RBEs) and progression-free (PFS)/overall survival (OS) in first-line therapy for metastatic colorectal cancer (mCRC) in the ARCAD database. [Internet]. Journal of Clinical Oncology. 2015 ; 33( 3S ):[citado 2026 maio 01 ] Available from: https://doi.org/10.1200/jco.2015.33.3_suppl.666
Artigo de periodico
Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database (2015)
Shi, Qian; Gramont, Aimery de; Grothey, Axel; Zalcberg, John; Chibaudel, Benoist; Schmoll, Hans-Joachim; Seymour, Matthew T.; Adams, Richard; Saltz, Leonard; Goldberg, Richard M.; Punt, Cornelis J. A.; Douillard, Jean-Yves; Hoff, Paulo M.; Hecht, Joel Randolph; Hurwitz, Herbert; Díaz-Rubio, Eduardo; Porschen, Rainer; Tebbutt, Niall C.; Fuchs, Charles; Souglakos, John; Falcone, Alfredo; Tournigand, Christophe; Kabbinavar, Fairooz F.; Heinemann, Volker; Cutsem, Eric Van; Bokemeyer, Carsten; Buyse, Marc; Sargent, Daniel J.
Source: Journal of Clinical Oncology. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, PROGNÓSTICO, METÁSTASE NEOPLÁSICA, ESTUDOS RANDOMIZADOS, NEOPLASIAS DO SISTEMA DIGESTÓRIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SHI, Qian et al. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database. Journal of Clinical Oncology, v. 33, n. 1, p. 22-28, 2015Tradução . . Disponível em: https://doi.org/10.1200/JCO.2014.56.5887. Acesso em: 01 maio 2026.
APA
Shi, Q., Gramont, A. de, Grothey, A., Zalcberg, J., Chibaudel, B., Schmoll, H. -J., et al. (2015). Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database. Journal of Clinical Oncology, 33( 1), 22-28. doi:10.1200/JCO.2014.56.5887
NLM
Shi Q, Gramont A de, Grothey A, Zalcberg J, Chibaudel B, Schmoll H-J, Seymour MT, Adams R, Saltz L, Goldberg RM, Punt CJA, Douillard J-Y, Hoff PM, Hecht JR, Hurwitz H, Díaz-Rubio E, Porschen R, Tebbutt NC, Fuchs C, Souglakos J, Falcone A, Tournigand C, Kabbinavar FF, Heinemann V, Cutsem EV, Bokemeyer C, Buyse M, Sargent DJ. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database [Internet]. Journal of Clinical Oncology. 2015 ; 33( 1): 22-28.[citado 2026 maio 01 ] Available from: https://doi.org/10.1200/JCO.2014.56.5887
Vancouver
Shi Q, Gramont A de, Grothey A, Zalcberg J, Chibaudel B, Schmoll H-J, Seymour MT, Adams R, Saltz L, Goldberg RM, Punt CJA, Douillard J-Y, Hoff PM, Hecht JR, Hurwitz H, Díaz-Rubio E, Porschen R, Tebbutt NC, Fuchs C, Souglakos J, Falcone A, Tournigand C, Kabbinavar FF, Heinemann V, Cutsem EV, Bokemeyer C, Buyse M, Sargent DJ. Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of the Digestive System Database [Internet]. Journal of Clinical Oncology. 2015 ; 33( 1): 22-28.[citado 2026 maio 01 ] Available from: https://doi.org/10.1200/JCO.2014.56.5887

USP Schools

ReP

Filtros

Authors

Subjects